The FTSE 100 is in no mans land, stuck in the middle of the recent range as an equilibrium is found between the optimism around the reopening of the global economy and fears of a second wave of coronavirus.
We also discuss the outlook for UK-listed shares at the forefront of fighting COVID-19 after the announcement of positive results from study involving a low cost steroid.
Register for the UK Investor Magazine Virtual Seminar 30th June:
https://event.webinarjam.com/register/7/10klvtx
Hosted on Acast. See acast.com/privacy for more information.
UK Investor Magazine